November 26, 2024

New Member: Welcome in our cluster to Cell Signaling Technology Europe B.V.

New Member: Welcome in our cluster to Cell Signaling Technology Europe B.V.
Go back

Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community.

CST empowers scientists worldwide with innovative, high-quality tools to advance discovery. Beyond science, CST prioritizes responsibility by partnering with communities and minimizing environmental impact. As the first life science member of 1% for the Planet, CST is committed to achieving net-zero emissions by 2029. Dedicated to good science and doing good, CST drives solutions for global challenges with care and integrity.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
13.2 million euros for new immunotherapies against Ewing sarcomas in children and adolescents

13.2 million euros for new immunotherapies against Ewing sarcomas in children and adolescents

The European research project THEODORA is launching during “Gold September”, the international childhood cancer awareness month. Researchers at the Heidelberg Medical Faculty of Heidelberg University, drawing on their expertise in clinical research and precision oncology at Hopp Children’s Cancer Center Heidelberg (KiTZ), are collaborating with Institut Curie in Paris, Prinses Máxima Centrum in Utrecht, and […]

read more
Light-Based 3D Printing: Innovative “Ink” Enables a Closed-Loop Material Cycle

Light-Based 3D Printing: Innovative “Ink” Enables a Closed-Loop Material Cycle

Heidelberg research team develops a polymer material that can be broken down into its individual components and reused Polymers used for light-based 3D printing are very stable due to their chemical structure, but they are typically hard to recycle. A research team led by Prof. Dr. Eva Blasco, a researcher at the Institute for Molecular […]

read more
Colon Cancer: How Highly Aggressive Tumors Evade the Immune System

Colon Cancer: How Highly Aggressive Tumors Evade the Immune System

Researchers from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have identified a previously unknown mechanism by which a particularly aggressive form of colon cancer evades the immune system. The findings show that the activation of a key signaling pathway helps cancer cells suppress the immune system, thereby promoting the development […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp